Syphilis Testing Market Expected to Reach $1.9 Billion by 2030—Allied Market Research

According to a new report published by Allied Market Research, titled, “Syphilis Testing Market," The syphilis testing market was valued at $1.1 billion in 2020, and is estimated to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030. 

Syphilis is a sexually transmitted disease caused by Treponema pallidum bacteria. Syphilis tests are used for screening and detection of antibodies against bacteria into the patients’ blood. There are various complications related to syphilis infection, such as infertility in both, men and women, ectopic pregnancy, cervical cancer in women and congenital mortality, and infections. Treponemal tests applied for the screening of bacterial infection includes the Treponema pallidum particle agglutination (TP-PA) and fluorescent treponemal antibody (FTA-ABS). Non-treponemal tests are relatively simple to perform and interpret, give rapid results, and are economic. However, non-treponemal tests require laboratory equipment and trained personnel to perform and interpret test reactions. Non-treponemal tests include, Rapid Plasma Reagin (RPR), which is an improved version of the Venereal Disease Research Laboratory (VDRL) test and tests for the same antigen.

The key factors that drive the growth of syphilis testing market size are rise in the prevalence of sexually transmitted disease and technological advancements. Moreover, improved healthcare infrastructure, rapid development in diagnostic kits, and availability of test kits are other factors that are expected to create opportunities for market growth during the forecast period. Furthermore, growth in incidences of diseases such as sexually transmitted disease, including syphilis has positively propelled the growth of the global syphilis testing market share. There are increasing incidences of the condition being transmitted by and among MSM (Men who have sex with men) population, injecting drug users, and sex workers. Syphilis constitutes a high proportion of health and economic burden for the developing countries. Especially, visits to the specialized STD clinics are noticed and to avoid uncomfortable situations or embarrassment in the society, many refrain from voluntary / CICT Syphilis testing at any of the labs or STD clinics. This hinders the uptake of diagnostic tests or testing volume, thus restraining the growth of the syphilis testing market.

The syphilis testing market analysis is segmented on the basis of type , location of testing  and geography. On the basis of type, the syphilis testing market growth is segmented into primary and secondary syphilis testing. On the basis of location of testing , the market is segmented into laboratory testing & point of care. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

By type, the syphilis testing market forecast is segment into primary and secondary syphilis testing market. The secondary syphilis segment holds the largest market share whereas the primary syphilis segment is estimated to witness the highest CAGR during the forecast period.

By location of testing, the syphilis testing industry is segmented into laboratory testing & point of care . The laboratory test segment is a highest market contributor in 2020. As laboratory testing is cost efficient, convenient and confidential the laboratory testing segment dominated the market in 2020 and is expected to continue this trend during the forecast period.

By region, the syphilis testing industry is analyzed across North America, Asia-Pacific, Europe, and LAMEA. LAMEA dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend during the forecast period. The prevalence and incidence rates of syphilis, typically have higher laboratory testing costs in LAMEA than in Asia-Pacific.

KEY FINDINGS OF STUDY

• By type, the secondary syphilis testing segment was the highest contributor to the market in 2020.
• By location of testing, the laboratory test segment was the highest contributor to the market in 2020.
• Region-wise, North America is the  largest revenue share in 2020. However, Europe  is anticipated to grow at the highest CAGR during the forecast period.